Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-006448

CEO sold 8,617 shares at $87.68 ($755,539)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Zovighian Bernard J · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-30 Sale : show line 1 in the form 10b5-1 −8,617 $87.68 $755,539 68,217.9 D
Open-market sales · 8,617 sh · avg $87.68 · $755,539
Loading xslF345X05/doc4.xml…